Press Release
Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies
April 30, 2025
Read MoreFrom precision diagnostics to radiopharmaceuticals—we pioneer next-generation solutions that help improve outcomes and lives.
It’s our purpose. Our passion. Making a difference in the lives of patients. Because we never forget that someone’s health is in our hands.
Press Release
April 30, 2025
Read MorePress Release
April 23, 2025
Read MorePress Release
April 1, 2025
Read MoreData provided by Nasdaq. Minimum 15 minutes delayed.
Looking to make a change that makes a difference? Our work at Lantheus puts patients first. Our innovations help clinicians Find, Fight and Follow® disease so that patients can achieve better outcomes. Take the first step in a new direction today.